Skip to main content
FinSpry Logo
FinSpry
VCEL logo
VCEL
(NASDAQ)
Vericel Corporation
$38.99-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Vericel (VCEL) Stock Price & Financial Analysis

Vericel Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$38.53 - $39.19
52-Week High$49.32
52-Week Low$28.95
Open$38.72
Volume366.51K
Average Volume (3M)483.89K
Market Cap2.04B
Shares Outstanding52.31M
P/E Ratio (TTM)84.21
Forward P/E41.66
Price to Sales (P/S)6.66
Price to Book (P/B)5.51
EV/EBITDA54.46
Revenue (TTM)306.30M
Net Income (TTM)24.22M
Free Cash Flow (TTM)49.64M
EPS (TTM)$0.47
Profit Margin7.91%
Operating Margin5.95%
Return on Equity (ROE)6.55%
Debt to Equity0.26
50-Day MA$44.44
200-Day MA$38.15
52-Week Change19.82%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Vericel

What is the current stock price for VCEL?

As of the latest trading session, VCEL stock trades at $38.99. The 52-week range is $28.95–$49.32, with a day range of $38.53–$39.19.

What is the P/E ratio for VCEL?

Vericel's trailing P/E ratio is 84.2, meaning investors pay $84.2 for every $1 of annual earnings. The forward P/E is 41.7, reflecting analyst expectations for future earnings. Vericel operates in the Healthcare sector.

Does VCEL pay dividends?

Vericel does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for VCEL?

Based on 1 analyst, the consensus for VCEL is Buy.

What is the market cap of VCEL?

Vericel's market capitalization is $2.04B, classifying it as a mid-cap company. Vericel operates in the Healthcare sector within the Biotechnology industry.